Inside the research

The Cigna Group

CI Research profile · latest available data

Price overview

$272.01

▲ +6.51 (+2.5%)

52w hi$304.11
52w lo$238.99
Vol1.82M
As of25 Sep 2026

The Verdict

Hold

Our score +0.33

Short+0.36
Medium+0.33
Long+0.29

computed 2026-09-27

Key fundamentals

The Cigna Group

Healthcare · Healthcare Plans

Market cap$71.88B
Enterprise value$96.79B
Trailing P/E11.25x
Forward P/E8.14x
EV / EBITDA7.59x
P / S (ttm)0.25x
Profit margin2.3%
Return on equity16.8%
Revenue growth+6.7%
Earnings growth+10.2%
Debt / equity74.29

Layer Breakdown

LayerRawContribution
Fundamental+0.25
Sector+0.08
Technical-0.04
Earnings+0.00
Sentiment+0.52

macro × 1.00 · 2026-09-27

Business overview

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

United States · www.thecignagroup.com

Risk Metrics

Beta vs SPX0.12
Corr SPX0.06
Annual vol31.2%
Annual ret-8.5%
Sharpe-0.27
Max DD-31.8%

Window: 504 trading days (504 obs)

Analyst Coverage

Mean PT$340.50
High / Low$378.00 / $290.00
Median$339.00
Analysts24
Strong Buy6
Buy16
Hold2
Sell0
Strong Sell0

Recent rating actions

2026-05-05Bernstein→ Outperform
2026-05-04Guggenheim→ Buy
2026-05-01Wells Fargo→ Equal-Weight
2026-05-01RBC Capital→ Outperform
2026-05-01Cantor Fitzgerald→ Overweight
2026-05-01Barclays→ Overweight

Officers & Board

DirectorNeesha Hathi since 2021
DirectorGeorge Kurian since 2021
DirectorKimberly Ross since 2020
DirectorElder Granger since 2018
DirectorMark McClellan since 2018
DirectorKathy Mazzarella since 2018
DirectorWilliam J. DeLaney III since 2018
DirectorEric J. Foss since 2011
DirectorDavid Cordani since 2009
DirectorEric Wiseman since 2007
DirectorIke Harris since 2005
DirectorDonna Zarcone since 2005
DirectorJohn Partridge 2009–2022

Material Events

DateEvent8-K
2026-07-30Earnings Release, Exhibitsread
2026-05-13Reg FD Disclosureread
2026-04-30Earnings Release, Exhibitsread
2026-04-27Shareholder Voteread
2026-03-03Officer / Director Change, Reg FD Disclosure…read
2026-02-27Reg FD Disclosureread
2026-02-05Earnings Release, Exhibitsread
2025-11-18Other Material Eventread
2025-10-30Earnings Release, Exhibitsread
2025-10-20Officer / Director Changeread
2025-09-04Material Agreement, Material Obligation…read
2025-09-02Reg FD Disclosureread

Insider Trades

DateInsiderRoleActionSharesValue
2026-08-05Jones Nicole SSee RemarksOption exercise1.30K$249.82K
2026-08-04Jones Nicole SSee RemarksSell19.44K$5.37M
2026-08-04Jones Nicole SSee RemarksOption exercise14.04K$2.70M
2026-06-12Kates Jamie GChief Accounting OfficerOption exercise899$137.45K
2026-06-12Kates Jamie GChief Accounting OfficerSell899$268.45K
2026-06-01Koka Durga PrasadEVP, Global CIOWithheld for tax729$200.86K
2026-05-13Cordani DavidChairman & CEOOption exercise7.97K$1.57M
2026-05-13Cordani DavidChairman & CEOOption exercise15.46K$2.31M
2026-05-12Cordani DavidChairman & CEOOption exercise85.52K$16.88M
2026-05-12Cordani DavidChairman & CEOOption exercise103.59K$15.45M

Flow & Concentration

Insider 180d net-$64.75M
Insider buys / sells0 / 15
Insider biasSellers
13F holders9
Top-5 share96.0%
HHI3,740 (concentrated)

Top Holders

HolderValueShares
State Street Corp$3.50B12.68M
Fidelity / FMR LLC$2.21B8.02M
AQR Capital Management$396.03M1.44M
Citadel Advisors$227.94M826.84K
Capital Research / Capital World$213.80M775.54K
Millennium Management$155.69M564.75K
Renaissance Technologies$95.25M345.50K
Bridgewater Associates$24.23M87.91K
T. Rowe Price Group$348.75K1.27M

As of 2026-06-30

Connections

Subsidiarys: Express Scripts

Suppliers: TFC, FREQ.V

Customers: FREQ.V, AND PROCEDURES A. Disclosure Co

Dividends

Yield (TTM)1.13%
$ / share (TTM)$3.07
5y CAGR+172.8%

Annual dividend per share

2021$4.00
2022$4.48
2023$4.92
2024$5.60
2025$6.04
2026$1.56

SEC Filings

DateFormDoc
2026-08-064view
2026-07-3010-Qview
2026-07-308-Kview
2026-07-093view
2026-07-093view
2026-07-093view
2026-07-093view
2026-07-093view
2026-06-2411-Kview
2026-06-164view
2026-06-034view
2026-06-024view
2026-05-144view
2026-05-138-Kview
2026-04-3010-Qview

The Long Run

FY 2018–2025 · 8 years

LineLatestCAGRTrend
Revenue$274.90B+59.6%
Operating income$9.42B+17.3%
Cash from ops$11.81B+17.7%

Indices

S&P 500

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$266.13$273.36$265.35$272.011.82M
Sep 24$267.90$269.33$263.76$265.501.61M
Sep 23$273.26$274.75$267.02$268.271.83M
Sep 22$276.85$278.47$272.73$273.741.47M
Sep 21$275.91$275.91$272.62$274.471.39M

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →